Last reviewed · How we verify

NCT06699732

Impact of Mindful Self-Compassion Therapy on Self Harm Behaviors, Emotional Regulation and Quality of Life Among Patients With Borderline Personality Disorder

Recruiting now NA Last updated 2 September 2025
What this trial tests

NA trial testing Mindful Self Compassion Therapy in Psychological Distress in 60 participants. Currently enrolling.

Timeline
21 September 2024
Primary endpoint
30 December 2025
30 December 2025

Quick facts

Lead sponsorFatima Jinnah Women University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposehealth services research
Enrollment60
Start date21 September 2024
Primary completion30 December 2025
Estimated completion30 December 2025
Sites2 locations across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Fatima Jinnah Women University

Who can join

18 and older, any sex, with Psychological Distress or Emotional Regulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary purpose of the study is to investigate whether Mindful Self-Compassion (MSC) therapy can significantly reduce self-harm behaviors, improve emotional regulation, and enhance the quality of life in individuals diagnosed with Borderline Personality Disorder (BPD). The study aims to contribute to the existing literature by providing robust evidence on the efficacy of MSC therapy for BPD, which could inform clinical practices and improve treatment outcomes

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Psychological Distress

Currently open trials in the same condition.

Other Fatima Jinnah Women University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06699732.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing